LogicBio Therapeutics Buy Hold or Sell Recommendation
| LOGCDelisted Stock | USD 2.07 0.00 0.00% |
Given the investment horizon of 90 days and your typical level of risk aversion, our recommendation regarding LogicBio Therapeutics is 'Not Rated'. Macroaxis provides LogicBio Therapeutics buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding LOGC positions. The advice algorithm takes into account all of LogicBio Therapeutics' available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting LogicBio Therapeutics' buy or sell advice are summarized below:
Real Value 1.38 | Hype Value 2.07 | Market Value 2.07 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell LogicBio Therapeutics given historical horizon and risk tolerance towards LogicBio Therapeutics. When Macroaxis issues a 'buy' or 'sell' recommendation for LogicBio Therapeutics, the advice is generated through an automated system that utilizes algorithms and statistical models.
LogicBio |
Execute LogicBio Therapeutics Buy or Sell Advice
The LogicBio recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on LogicBio Therapeutics. Macroaxis does not own or have any residual interests in LogicBio Therapeutics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute LogicBio Therapeutics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
LogicBio Therapeutics Trading Alerts and Improvement Suggestions
| LogicBio Therapeutics is not yet fully synchronised with the market data | |
| LogicBio Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 5.41 M. Net Loss for the year was (40.03 M) with loss before overhead, payroll, taxes, and interest of (22.76 M). | |
| LogicBio Therapeutics currently holds about 38.85 M in cash with (19 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.18. |
LogicBio Therapeutics Returns Distribution Density
The distribution of LogicBio Therapeutics' historical returns is an attempt to chart the uncertainty of LogicBio Therapeutics' future price movements. The chart of the probability distribution of LogicBio Therapeutics daily returns describes the distribution of returns around its average expected value. We use LogicBio Therapeutics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of LogicBio Therapeutics returns is essential to provide solid investment advice for LogicBio Therapeutics.
| Mean Return | 9.18 | Value At Risk | -5.26 | Potential Upside | 5.56 | Standard Deviation | 207.00 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of LogicBio Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
LogicBio Therapeutics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as LogicBio . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About LogicBio Therapeutics Buy or Sell Advice
When is the right time to buy or sell LogicBio Therapeutics? Buying financial instruments such as LogicBio Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having LogicBio Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Macroaxis Picks Thematic Idea Now
Macroaxis Picks
Daily selected watch list of stocks of large companies handpicked by Macroaxis Team based on their diversification potential. The Macroaxis Picks theme has 50 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Macroaxis Picks Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the LogicBio Therapeutics information on this page should be used as a complementary analysis to other LogicBio Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Consideration for investing in LogicBio Stock
If you are still planning to invest in LogicBio Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the LogicBio Therapeutics' history and understand the potential risks before investing.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |